You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company's RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome.
Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share.
Waters posted revenues of $593.8 million in Q3 compared to $577.3 million in Q3 2019 and beating the average Wall Street estimate of $546.5 million.
A decade after its launch, the effort has detected almost 18,000 human proteins and is shifting its focus more on different protein forms and functional data.
A group of 11 labs around the world found that use of a QA/QC process allowed them to collect highly reproducible DIA proteomic data across sites.
The team plans to begin development work at InterVenn Malaysia's laboratory at Technology Park Malaysia in Kuala Lumpur.
The researchers also developed a web-based tool based on the data they gathered that could help predict COVID-19 severity in patients.
The tests are designed to detect viral nucleic acid in various respiratory specimens including nasal swabs, nasal aspirate, and bronchoalveolar lavage.
Called the Integrated Proteomics Pipeline, the platform offers search engine capabilities that will enable better use of collision cross section data.
Investigators identified disease-associated histone modifications in the brain that appeared to influence transcription- and chromatin-related processes.
Investors included Bruker, whose MALDI mass spectrometry imaging platforms could have synergies with Ionpath's Multiplexed Ion Beam Imaging technology.
Planned and ongoing studies will use standardized plasma protein profiling workflows to discover biomarkers for a range of conditions.
Instead of measuring metabolites directly, the researchers used mass cytometry and multiplexed ion beam imaging to measure proteins involved in metabolic regulation.
Working with ETH Zurich researchers, the firm has incorporated machine learning to improve the platform's performance in complex organisms like humans.
The method uses DIA mass spec runs to adjust for drifts in LC retention times, allowing researchers to schedule more highly multiplexed experiments.
The firm said it plans to use the proceeds to support the launch of its first product based on its structures for lossless ion manipulation ion mobility system.
Recently developed deep learning tools and other software packages have streamlined DIA mass spec workflows and are driving uptake within proteomics cores.
The pair are working on reagents and mass spec approaches to improve isolation and analysis of crosslinked peptides for protein interaction and structural studies.
The Singapore-based company will use the funds to expand its presence in the US and develop its platform, which uses mass cytometry to profile T-cell response.
The collaborators will develop methods using Bruker's timsTOF Pro for structural and protein interaction work that the company plans to commercialize.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.